Use of Reticulocyte Ratio and Neutrophil / Lymphocyte Ratio in the Diagnosis of Ventilator-associated Pneumonia
1 other identifier
observational
35
1 country
1
Brief Summary
In this study, the utility of changes in the ratio of Ret-He and NLR as an early inflammation marker for VAP will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2020
CompletedFirst Posted
Study publicly available on registry
November 9, 2020
CompletedStudy Start
First participant enrolled
February 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2023
CompletedNovember 6, 2024
November 1, 2024
1.6 years
November 3, 2020
November 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early inflammation markers for VAP
To investigate the use of NLR and Ret-He value as early inflammation markers for VAP.
7 days
Secondary Outcomes (1)
morbidity and mortality
7 days
Study Arms (1)
ventilator-associated pneumonia
Ret-He values will be studied on the day (1st day), 4th and 7th days of VID diagnosis in patients receiving mechanical ventilation support in the intensive care unit. The hemogram, CRP, and NLR values that are routinely studied in the intensive care unit will be recorded. In addition, in case of infection, the routinely studied procalcitonin value will also be recorded. The patient's age, gender, APACHE II, SOFA scores will be recorded; respiratory system examination, fever, the mental status evaluation will be done daily.
Interventions
Ret-He values will be studied on the day (1st day), 4th and 7th days of the diagnosis of ventilator-associated pneumonia in patients hospitalized in the intensive care unit.
Eligibility Criteria
Patients who need mechanical ventilation for longer than 48 hours for a noninfectious reason in the intensive care unit
You may qualify if:
- Patients who need mechanical ventilation for longer than 48 hours for a noninfectious reason in the intensive care unit
You may not qualify if:
- Pulmonary or extrapulmonary infection before mechanical ventilation,
- severe immunosuppression,
- bleeding in the gastrointestinal system,
- using corticosteroids,
- neoplastic disease history
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mugla Sitki Kocman Universty
Muğla, Kötekli, 48000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
turhan togan
Mugla Sitki Kocman Universty Department of Infection Disease
- STUDY CHAIR
Canan Gursoy
Mugla Sitki Kocma University Department of Intensive Care
- STUDY CHAIR
Semra Demirbilek
Mugla Sitki Kocman Universty Department of Anesthesia
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Muğla Sıtkı Koçman University Department of Anesthesiology Specialist
Study Record Dates
First Submitted
November 3, 2020
First Posted
November 9, 2020
Study Start
February 21, 2022
Primary Completion
September 21, 2023
Study Completion
December 21, 2023
Last Updated
November 6, 2024
Record last verified: 2024-11